← Back to Search

BRAVE Intervention for COVID-19 (BRAVE Trial)

N/A
Waitlist Available
Led By Deepak Kumar, PhD
Research Sponsored by North Carolina Central University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- Self reports as Native American or American Indian
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

BRAVE Trial Summary

This study is evaluating whether COVID-19 testing and vaccination are acceptable to American Indian communities.

Eligible Conditions
  • COVID-19

BRAVE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

BRAVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Increase in COVID-19 testing
Increase in COVID-19 vaccination

BRAVE Trial Design

2Treatment groups
Active Control
Group I: BRAVE Non-InterventionActive Control1 Intervention
Survey participants in the BRAVE non-intervention arm will not have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.
Group II: BRAVE InterventionActive Control1 Intervention
Survey participants in the BRAVE intervention arm will have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.

Find a Location

Who is running the clinical trial?

North Carolina Central UniversityLead Sponsor
3 Previous Clinical Trials
10,678 Total Patients Enrolled
Lumbee Tribe of North CarolinaUNKNOWN
University of North Carolina at PembrokeUNKNOWN

Frequently Asked Questions

~960 spots leftby Apr 2025